187 related articles for article (PubMed ID: 35147461)
1. Evaluation of lung cancer biomarkers profile for the decision of targeted therapy in EBUS-TBNA cytological samples.
Gürün Kaya A; Çiledağ A; Erol S; Öz M; Doğan Mülazımoğlu D; Işık Ö; Özakıncı H; Çiftçi F; Şen E; Ceyhan K; Kaya A; Karnak D; Çelik G; İsmail S
Scott Med J; 2022 Feb; 67(1):18-27. PubMed ID: 35147461
[TBL] [Abstract][Full Text] [Related]
2. Suitability of endobronchial ultrasound-guided transbronchial needle aspiration samples for programmed death ligand-1 testing in non-small cell lung cancer, the Bristol experience.
Hardy J; Bhatt N; Medford ARL
Asia Pac J Clin Oncol; 2022 Apr; 18(2):e32-e38. PubMed ID: 33870634
[TBL] [Abstract][Full Text] [Related]
3. Adequacy of EBUS-TBNA specimen for mutation analysis of lung cancer.
Cicek T; Ozturk A; Yılmaz A; Aktas Z; Demirag F; Akyurek N
Clin Respir J; 2019 Feb; 13(2):92-97. PubMed ID: 30582673
[TBL] [Abstract][Full Text] [Related]
4. Comparison of PD-L1, EGFR, ALK, and ROS1 Status Between Surgical Samples and Cytological Samples in Non-Small Cell Lung Carcinoma.
Ekin Z; Nart D; Savaş P; Veral A
Balkan Med J; 2021 Sep; 38(5):287-295. PubMed ID: 34558414
[TBL] [Abstract][Full Text] [Related]
5. Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy.
Faber E; Grosu H; Sabir S; San Lucas FA; Barkoh BA; Bassett RL; Luthra R; Stewart J; Roy-Chowdhuri S
J Clin Pathol; 2022 Sep; 75(9):612-619. PubMed ID: 33952592
[TBL] [Abstract][Full Text] [Related]
6. Adequacy of cytology and small biopsy samples obtained with rapid onsite evaluation (ROSE) for predictive biomarker testing in non-small cell lung cancer.
Hendry S; Mamotte L; Mesbah Ardakani N; Leslie C; Tesfai Y; Grieu-Iacopetta F; Izaac K; Singh S; Ardakani R; Thomas M; Giardina T; Robinson C; Frost F; Amanuel B
Pathology; 2023 Dec; 55(7):917-921. PubMed ID: 37805343
[TBL] [Abstract][Full Text] [Related]
7. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for PD-L1 Testing in Non-small Cell Lung Cancer.
Perrotta F; Nankivell M; Adizie JB; Maqsood U; Elshafi M; Jafri S; Lerner AD; Woolhouse I; Munavvar M; Evison M; Booton R; Baldwin DR; Janes SM; Kerr KM; Bianco A; Yarmus L; Navani N
Chest; 2020 Sep; 158(3):1230-1239. PubMed ID: 32428509
[TBL] [Abstract][Full Text] [Related]
8. Handling and standardization of EBUS needle aspiration in NSCLC patients: The value of the cell block, a monoinstitutional experience.
Parente P; Carbonelli C; Biancofiore G; Sukthi A; Di Micco CM; Vairo M; Fuso P; Taurchini M; Graziano P
Thorac Cancer; 2022 Sep; 13(17):2480-2488. PubMed ID: 35868633
[TBL] [Abstract][Full Text] [Related]
9. Adequacy of Samples Obtained by Endobronchial Ultrasound with Transbronchial Needle Aspiration for Molecular Analysis in Patients with Non-Small Cell Lung Cancer. Systematic Review and Meta-Analysis.
Labarca G; Folch E; Jantz M; Mehta HJ; Majid A; Fernandez-Bussy S
Ann Am Thorac Soc; 2018 Oct; 15(10):1205-1216. PubMed ID: 30011388
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis in cytological samples obtained by endobronchial or oesophageal ultrasound guided needle aspiration in non-small cell lung cancer.
Centeno C; Serra Mitja P; Avila M; Carcereny E; Muñoz-Mármol AM; Moran T; Castellà E; Sanz-Santos J; García Olivé I; Ramirez Serrano JL; Rosell Gratacos A; Andreo García F
Pulmonology; 2022; 28(1):28-33. PubMed ID: 32507497
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Programmed Death Ligand-1 Immunohistochemical Staining Between Endobronchial Ultrasound Transbronchial Needle Aspiration and Resected Lung Cancer Specimens.
Sakata KK; Midthun DE; Mullon JJ; Kern RM; Nelson DR; Edell ES; Schiavo DN; Jett JR; Aubry MC
Chest; 2018 Oct; 154(4):827-837. PubMed ID: 30059678
[TBL] [Abstract][Full Text] [Related]
12. Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer.
Esterbrook G; Anathhanam S; Plant PK
Lung Cancer; 2013 Apr; 80(1):30-4. PubMed ID: 23312886
[TBL] [Abstract][Full Text] [Related]
13. The prognostic role of PD-1, PD-L1, ALK, and ROS1 proteins expression in non-small cell lung carcinoma patients from Egypt.
Bahnassy AA; Ismail H; Mohanad M; El-Bastawisy A; Yousef HF
J Egypt Natl Canc Inst; 2022 May; 34(1):23. PubMed ID: 35644823
[TBL] [Abstract][Full Text] [Related]
14. Endobronchial Ultrasound Guided Transbronchial Needle Aspiration and PD-L1 Yields.
Khoury LM; Sheehan KN; Mariencheck WI; Gershner KA; Maslonka M; Niehaus AG; Isom S; Bellinger CR
Lung; 2024 Jun; 202(3):325-330. PubMed ID: 38637361
[TBL] [Abstract][Full Text] [Related]
15. Clinical performance of endobronchial ultrasound-guided transbronchial needle aspiration for assessing programmed death ligand-1 expression in nonsmall cell lung cancer.
Biswas A; Leon ME; Drew P; Fernandez-Bussy S; Furtado LV; Jantz MA; Mehta HJ
Diagn Cytopathol; 2018 May; 46(5):378-383. PubMed ID: 29476608
[TBL] [Abstract][Full Text] [Related]
16. Real-World Outcomes of Patients With Advanced Non-small Cell Lung Cancer Treated With Anti-PD1 Therapy on the Basis of PD-L1 Results in EBUS-TBNA vs Histological Specimens.
Tajarernmuang P; Ofiara L; Beaudoin S; Wang H; Benedetti A; Gonzalez AV
Chest; 2021 Aug; 160(2):743-753. PubMed ID: 33675792
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity analysis of PD-L1 expression and copy number status in EBUS-TBNA biopsy specimens of non-small cell lung cancer: Comparative assessment of primary and metastatic sites.
Yoshimura K; Inoue Y; Karayama M; Tsuchiya K; Mori K; Suzuki Y; Iwashita Y; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Yokomura K; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
Lung Cancer; 2019 Aug; 134():202-209. PubMed ID: 31319982
[TBL] [Abstract][Full Text] [Related]
18. Pilot Study of the Performance of 19-G Needle in Endobronchial Ultrasound-guided Transbronchial Aspiration for the Diagnosis and Testing of Molecular Markers in Lung Cancer.
Wahidi MM; Davidson K; Shofer S; Mahmood K; Cheng G; Giovacchini C; Jones C; Jug R; Pavlisko EN; Wang X; Gu L; Weimholt C; Zhou Z; Chen A
J Bronchology Interv Pulmonol; 2021 Jul; 28(3):209-214. PubMed ID: 33273249
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration to assess tumor-programmed cell death ligand-1 expression in mediastinal lymph nodes metastasized from non-small cell lung cancer.
Mineura K; Hamaji M; Yoshizawa A; Nakajima N; Kayawake H; Tanaka S; Yamada Y; Yutaka Y; Nakajima D; Ohsumi A; Menju T; Chen-Yoshikawa TF; Date H
Surg Today; 2020 Sep; 50(9):1049-1055. PubMed ID: 32166496
[TBL] [Abstract][Full Text] [Related]
20. Programmed Death Ligand 1 Testing of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Samples Acquired For the Diagnosis and Staging of Non-Small Cell Lung Cancer.
Smith A; Wang H; Zerbo A; Beaudoin S; Ofiara L; Fiset PO; Benedetti A; Gonzalez AV
J Bronchology Interv Pulmonol; 2020 Jan; 27(1):50-57. PubMed ID: 31513030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]